Thursday, Oct 6 2022 | Time 16:13 Hrs(IST)
Business Economy

BE's Corbevaxtm receives DCGI approval

Hyderabad, Dec 28 (UNI) Biological E. Limited (BE), one of the world’s largest vaccine manufacturers on Tuesday announced that its Corbevaxtm, India’s first indigenously developed protein sub-unit vaccine against COVID-19, received the approval from the Drugs Controller General of India (DGCI).

Corbevaxtm is a “recombinant protein sub-unit” vaccine, developed from the Receptor Binding Domain (RBD) of the spike protein on the virus’s surface combined with Dynavax’s CpG 1018 adjuvant with alum, which helps the body build the immune response against the virus.
The vaccine has been developed by BE in collaboration with Texas Children’s Hospital Center for Vaccine Development (Texas Children’s CVD) and Baylor College of Medicine (Baylor) in Houston, Texas, a company release here said on Tuesday.

The vaccine will be effective both in scale and affordability, providing sustainable access to low-and middle-income countries.

Biological E Limited's Corbevaxtim has completed two Phase III clinical trials involving more than 3000 subjects between the ages of 18 and 80 at 33 study sites across India. The vaccine was found to be safe, well tolerated and immunogenic, the release said.

The Government of India, Ministry of Health & Family Welfare said, “We are glad that India has produced yet another COVID-19 vaccine.
We believe that this vaccine will address the needs of the world and help the global population fighting against the spread of COVID-19.
Biological E. Limited plans to complete production at a rate of 75 Million doses per month, anticipating 100+ million doses per month from February 2022.
These capacities will enable the Hyderabad-based company to deliver 300 Million doses as promised to the Government of India. Soon, the company plans to deliver more than one billion additional doses globally, the release said.
More News
Sensex up 156 63 points

Sensex up 156 63 points

06 Oct 2022 | 3:59 PM

Mumbai, Oct 6 (UNI) The BSE Sensex on Thursday added another 156.63 points to close strong at 58,222.10 as renewed buying was witnessed in Metal, Capital Goods, Realty and Industrials stocks.

see more..

Mahindra Lifespaces forms JV with Actis

06 Oct 2022 | 12:13 PM

Mumbai, Oct 6 (UNI) Mahindra Lifespace Developers Ltd, the real estate and infrastructure development arm of the Mahindra Group, on Thursday said it has entered into an agreement with Actis, a leading global investor in sustainable infrastructure, to establish a Joint Venture Platform for developing industrial and logistics real estate facilities across India.

see more..

Mafia Trends lists on BSE SME Platform

06 Oct 2022 | 12:10 PM

Mumbai, Oct 6 (UNI) Mafia Trends became the 394th company to get listed on the BSE SME Platform on Thursday.

see more..

Falca raises over USD 3 million

06 Oct 2022 | 12:08 PM

Mumbai, Oct 6 (UNI) Agri-tech platform Falcasaid said it has raised over USD 3 million in Pre-Series A round led by Inflection Point Ventures, along with a combination of debt and equity funding.

see more..

Glenmark to launch Lobeglitazone

06 Oct 2022 | 12:05 PM

Mumbai, Oct 6 (UNI) Pharma major Glenmark Pharma became the first to launch Thiazolidinedione Lobeglitazone (Lobeglitazone) in India for the treatment of type 2 diabetes in adults.

see more..